Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy

A study from southern Italy

F. Russo, P. Berloco, R. Cuomo, M. L. Caruso, G. Di Matteo, P. Giorgio, V. De Francesco, A. Di Leo, E. Ierardi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Certain evidence suggests that Helicobacter pylori strains expressing genes for cytotoxin production show a higher sensitivity than non-cytotoxic organisms to eradication treatment. No data are available on the involvement of bacterium-related lesions in different therapeutic outcomes. Aims: (i) To investigate whether differences in eradication rates may be related to the different expression of virulent strains (cagA, vacA, iceA) in patients undergoing proton pump inhibitor-based triple therapy, and (ii) to evaluate whether therapeutic outcome may be affected by bacterium-induced gastric lesions. Methods: One hundred and ten H. pylori-positive subjects were enrolled. H. pylori was genotyped by polymerase chain reaction. Treatment consisted of lansoprazole-amoxicillin-clarithromycin, twice daily for 1 week. Eradication was checked by urea breath test. Results: The eradication rate was 70%, and the absence of cagA was associated with unsuccessful treatment. No difference between the groups with successful and unsuccessful eradication was found with regard to vacA and iceA. Lympho-epithelial lesions and fibrosis were associated with unsuccessful treatment. Conclusions: The present data confirm the importance of cagA (but not vacA and iceA) as a predictor of successful eradication. When fibrosis and lympho-epithelial lesions are present, therapy appears to be less effective. Therefore, these histological features may be involved in an unsuccessful therapeutic outcome.

Original languageEnglish
Pages (from-to)421-428
Number of pages8
JournalAlimentary Pharmacology and Therapeutics
Volume17
Issue number3
DOIs
Publication statusPublished - Feb 1 2003

Fingerprint

Helicobacter pylori
Italy
Therapeutics
Fibrosis
Lansoprazole
Bacteria
Breath Tests
Clarithromycin
Proton Pump Inhibitors
Amoxicillin
Cytotoxins
Urea
Stomach
Polymerase Chain Reaction
Genes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy : A study from southern Italy. / Russo, F.; Berloco, P.; Cuomo, R.; Caruso, M. L.; Di Matteo, G.; Giorgio, P.; De Francesco, V.; Di Leo, A.; Ierardi, E.

In: Alimentary Pharmacology and Therapeutics, Vol. 17, No. 3, 01.02.2003, p. 421-428.

Research output: Contribution to journalArticle

@article{2d75d276a41c4491a94eb1bf53b7d35e,
title = "Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: A study from southern Italy",
abstract = "Background: Certain evidence suggests that Helicobacter pylori strains expressing genes for cytotoxin production show a higher sensitivity than non-cytotoxic organisms to eradication treatment. No data are available on the involvement of bacterium-related lesions in different therapeutic outcomes. Aims: (i) To investigate whether differences in eradication rates may be related to the different expression of virulent strains (cagA, vacA, iceA) in patients undergoing proton pump inhibitor-based triple therapy, and (ii) to evaluate whether therapeutic outcome may be affected by bacterium-induced gastric lesions. Methods: One hundred and ten H. pylori-positive subjects were enrolled. H. pylori was genotyped by polymerase chain reaction. Treatment consisted of lansoprazole-amoxicillin-clarithromycin, twice daily for 1 week. Eradication was checked by urea breath test. Results: The eradication rate was 70{\%}, and the absence of cagA was associated with unsuccessful treatment. No difference between the groups with successful and unsuccessful eradication was found with regard to vacA and iceA. Lympho-epithelial lesions and fibrosis were associated with unsuccessful treatment. Conclusions: The present data confirm the importance of cagA (but not vacA and iceA) as a predictor of successful eradication. When fibrosis and lympho-epithelial lesions are present, therapy appears to be less effective. Therefore, these histological features may be involved in an unsuccessful therapeutic outcome.",
author = "F. Russo and P. Berloco and R. Cuomo and Caruso, {M. L.} and {Di Matteo}, G. and P. Giorgio and {De Francesco}, V. and {Di Leo}, A. and E. Ierardi",
year = "2003",
month = "2",
day = "1",
doi = "10.1046/j.1365-2036.2003.01443.x",
language = "English",
volume = "17",
pages = "421--428",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy

T2 - A study from southern Italy

AU - Russo, F.

AU - Berloco, P.

AU - Cuomo, R.

AU - Caruso, M. L.

AU - Di Matteo, G.

AU - Giorgio, P.

AU - De Francesco, V.

AU - Di Leo, A.

AU - Ierardi, E.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Background: Certain evidence suggests that Helicobacter pylori strains expressing genes for cytotoxin production show a higher sensitivity than non-cytotoxic organisms to eradication treatment. No data are available on the involvement of bacterium-related lesions in different therapeutic outcomes. Aims: (i) To investigate whether differences in eradication rates may be related to the different expression of virulent strains (cagA, vacA, iceA) in patients undergoing proton pump inhibitor-based triple therapy, and (ii) to evaluate whether therapeutic outcome may be affected by bacterium-induced gastric lesions. Methods: One hundred and ten H. pylori-positive subjects were enrolled. H. pylori was genotyped by polymerase chain reaction. Treatment consisted of lansoprazole-amoxicillin-clarithromycin, twice daily for 1 week. Eradication was checked by urea breath test. Results: The eradication rate was 70%, and the absence of cagA was associated with unsuccessful treatment. No difference between the groups with successful and unsuccessful eradication was found with regard to vacA and iceA. Lympho-epithelial lesions and fibrosis were associated with unsuccessful treatment. Conclusions: The present data confirm the importance of cagA (but not vacA and iceA) as a predictor of successful eradication. When fibrosis and lympho-epithelial lesions are present, therapy appears to be less effective. Therefore, these histological features may be involved in an unsuccessful therapeutic outcome.

AB - Background: Certain evidence suggests that Helicobacter pylori strains expressing genes for cytotoxin production show a higher sensitivity than non-cytotoxic organisms to eradication treatment. No data are available on the involvement of bacterium-related lesions in different therapeutic outcomes. Aims: (i) To investigate whether differences in eradication rates may be related to the different expression of virulent strains (cagA, vacA, iceA) in patients undergoing proton pump inhibitor-based triple therapy, and (ii) to evaluate whether therapeutic outcome may be affected by bacterium-induced gastric lesions. Methods: One hundred and ten H. pylori-positive subjects were enrolled. H. pylori was genotyped by polymerase chain reaction. Treatment consisted of lansoprazole-amoxicillin-clarithromycin, twice daily for 1 week. Eradication was checked by urea breath test. Results: The eradication rate was 70%, and the absence of cagA was associated with unsuccessful treatment. No difference between the groups with successful and unsuccessful eradication was found with regard to vacA and iceA. Lympho-epithelial lesions and fibrosis were associated with unsuccessful treatment. Conclusions: The present data confirm the importance of cagA (but not vacA and iceA) as a predictor of successful eradication. When fibrosis and lympho-epithelial lesions are present, therapy appears to be less effective. Therefore, these histological features may be involved in an unsuccessful therapeutic outcome.

UR - http://www.scopus.com/inward/record.url?scp=0037327914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037327914&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.2003.01443.x

DO - 10.1046/j.1365-2036.2003.01443.x

M3 - Article

VL - 17

SP - 421

EP - 428

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 3

ER -